Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vertex Pharma shares jump more than 20% on cystic fibrosis study results
Vertex Pharma shares jump more than 20% on cystic fibrosis study results
Vertex Pharma shares jump more than 20% on cystic fibrosis study results
Submitted by
admin
on March 28, 2017 - 11:54pm
Source:
Marketwatch
News Tags:
Vertex Pharmaceuticals
cystic fibrosis
tezacaftor
Kalydeco
clinical trials
Headline:
Vertex Pharma shares jump more than 20% on cystic fibrosis study results
Do Not Allow Advertisers to Use My Personal information
